Byung Chull An
Overview
Explore the profile of Byung Chull An including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang S, Kim Y, Yeo H, Yeo H, Kang G, An B, et al.
Int J Stem Cells
. 2024 Nov;
18(1):87-98.
PMID: 39491493
Probiotics exert various effects on the body and provide different health benefits. Previous reports have demonstrated that the P8 protein (P8), isolated from Lactobacillus rhamnosus, has anticancer properties. However, its...
2.
An B, Kwak S, Ahn J, Won H, Kim T, Ryu Y, et al.
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338524
L. (Banaba) has been used as a functional food because of its diuretic, decongestant, antipyretic, anti-hyperglycemic, and anti-adipogenic activities. Triterpene acids, including corosolic acid, oleanolic acid, and asiatic acid, are...
3.
An B, Ahn J, Kwon D, Kwak S, Heo J, Kim S, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373005
A novel probiotics-derived protein, P8, suppresses the growth of colorectal cancer (CRC). P8 can penetrate the cell membrane via endocytosis and cause cell cycle arrest in DLD-1 cells through down-regulation...
4.
An B, Yoon Y, Park H, Park S, Kim T, Ahn J, et al.
Drug Des Devel Ther
. 2021 Dec;
15:4761-4793.
PMID: 34866901
Purpose: This study aimed to toxicological evaluate a probiotics-based delivery system for p8 protein as an anti-colorectal cancer drug. Introduction: Lactic acid bacteria (LAB) have been widely ingested for many...
5.
Chung Y, Ryu Y, An B, Yoon Y, Choi O, Kim T, et al.
Microbiome
. 2021 May;
9(1):122.
PMID: 34039418
Background: Successful chemoprevention or chemotherapy is achieved through targeted delivery of prophylactic agents during initial phases of carcinogenesis or therapeutic agents to malignant tumors. Bacteria can be used as anticancer...
6.
An B, Ryu Y, Yoon Y, Choi O, Park H, Kim T, et al.
Mol Cells
. 2019 Nov;
42(11):755-762.
PMID: 31707776
Despite decades of research into colorectal cancer (CRC), there is an ongoing need for treatments that are more effective and safer than those currently available. Lactic acid bacteria (LAB) show...
7.
An B, Hong S, Park H, Kim B, Ahn J, Ryu Y, et al.
Genes (Basel)
. 2019 Aug;
10(8).
PMID: 31430963
Recently, we reported a novel therapeutic probiotic-derived protein, p8, which has anti-colorectal cancer (anti-CRC) properties. In vitro experiments using a CRC cell line (DLD-1), anti-proliferation activity (about 20%) did not...
8.
Choi J, An B, Jung I, Kim J, Lee S
Gene
. 2019 Mar;
700:163-167.
PMID: 30898707
Glutathione peroxidase 3 (GPx3), a major antioxidant enzyme in plasma, catalyzes the reduction of HO, lipid peroxides and organic hydroperoxides by reducing glutathione (GSH). Hypermethylation of the GPx3 promoter and...
9.
An B, Choi Y, Oh I, Kim J, Park J, Lee S
PLoS One
. 2018 Sep;
13(9):e0204170.
PMID: 30260967
Glutathione peroxidase 3 (GPx3), a major scavenger of reactive oxygen species (ROS) in plasma, acts as a redox signal modulator. However, the mechanism underlying GPx3-mediated suppression of cancer cell growth...
10.
Shin J, Song S, Ahn H, An B, Choi Y, Yang E, et al.
PLoS One
. 2017 Aug;
12(8):e0183896.
PMID: 28837649
Non-small-cell lung cancer (NSCLC) constitutes approximately 80% of all diagnosed lung cancers, and diagnostic markers detectable in the plasma/serum of NSCLC patients are greatly needed. In this study, we established...